Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Blood ; 135(21): 1899-1911, 2020 05 21.
Article in English | MEDLINE | ID: mdl-32128578

ABSTRACT

Hemophilia A, an X-linked bleeding disorder caused by deficiency of factor VIII (FVIII), is treated by protein replacement. Unfortunately, this regimen is costly due to the expense of producing recombinant FVIII as a consequence of its low-level secretion from mammalian host cells. FVIII expression activates the endoplasmic reticulum (ER) stress response, causes oxidative stress, and induces apoptosis. Importantly, little is known about the factors that cause protein misfolding and aggregation in metazoans. Here, we identified intrinsic and extrinsic factors that cause FVIII to form aggregates. We show that FVIII forms amyloid-like fibrils within the ER lumen upon increased FVIII synthesis or inhibition of glucose metabolism. Significantly, FVIII amyloids can be dissolved upon restoration of glucose metabolism to produce functional secreted FVIII. Two ER chaperone families and their cochaperones, immunoglobulin binding protein (BiP) and calnexin/calreticulin, promote FVIII solubility in the ER, where the former is also required for disaggregation. A short aggregation motif in the FVIII A1 domain (termed Aggron) is necessary and sufficient to seed ß-sheet polymerization, and BiP binding to this Aggron prevents amyloidogenesis. Our findings provide novel insight into mechanisms that limit FVIII secretion and ER protein aggregation in general and have implication for ongoing hemophilia A gene-therapy clinical trials.


Subject(s)
Amyloid/chemistry , Endoplasmic Reticulum Stress/drug effects , Endoplasmic Reticulum/drug effects , Factor VIII/metabolism , Glucose/pharmacology , Molecular Chaperones/metabolism , Amyloid/drug effects , Endoplasmic Reticulum/metabolism , Factor VIII/genetics , Hemostatics , Hep G2 Cells , Humans , Molecular Chaperones/genetics , Sweetening Agents/pharmacology
2.
Sci Rep ; 13(1): 22562, 2023 12 19.
Article in English | MEDLINE | ID: mdl-38110611

ABSTRACT

The detection of pathogens is critical for clinical diagnosis and public health surveillance. Detection is usually done with nucleic acid-based tests (NATs) and rapid antigen tests (e.g., lateral flow assays [LFAs]). Although NATs are more sensitive and specific, their use is often limited in resource-poor settings due to specialized requirements. To address this limitation, we developed a rapid DNA-RNA Hybrid Capture immunoassay (HC) that specifically detects RNA from pathogens. This assay utilizes a unique monoclonal antibody, S9.6, which binds DNA-RNA hybrids. Biotinylated single-stranded DNA probes are hybridized to target RNAs, followed by hybrid capture on streptavidin and detection with S9.6. The HC-ELISA assay can detect as few as 104 RNA molecules that are 2.2 kb in length. We also adapted this assay into a LFA format, where captured Bacillus anthracis rpoB RNA of 3.5 kb length was detectable from a bacterial load equivalent to 107 CFU per 100 mg of mouse tissue using either HC-ELISA or HC-LFA. Importantly, we also demonstrated the versatility of HC by detecting other pathogens, including SARS-CoV-2 and Toxoplasma gondii, showing its potential for broad pathogen detection. Notably, HC does not require amplification of the target nucleic acid and utilizes economical formats like ELISA and LFA, making it suitable for use in sentinel labs for pathogen detection or as a molecular tool in basic research laboratories. Our study highlights the potential of HC as a sensitive and versatile method for RNA-based pathogen detection.


Subject(s)
Nucleic Acids , SARS-CoV-2 , Mice , Animals , Immunoassay/methods , RNA , DNA
3.
Elife ; 82019 09 09.
Article in English | MEDLINE | ID: mdl-31498082

ABSTRACT

The endoplasmic reticulum (ER) imports ATP and uses energy from ATP hydrolysis for protein folding and trafficking. However, little is known about how this vital ATP transport occurs across the ER membrane. Here, using three commonly used cell lines (CHO, INS1 and HeLa), we report that ATP enters the ER lumen through a cytosolic Ca2+-antagonized mechanism, or CaATiER (Ca2+-Antagonized Transport into ER). Significantly, we show that mitochondria supply ATP to the ER and a SERCA-dependent Ca2+ gradient across the ER membrane is necessary for ATP transport into the ER, through SLC35B1/AXER. We propose that under physiological conditions, increases in cytosolic Ca2+ inhibit ATP import into the ER lumen to limit ER ATP consumption. Furthermore, the ATP level in the ER is readily depleted by oxidative phosphorylation (OxPhos) inhibitors and that ER protein misfolding increases ATP uptake from mitochondria into the ER. These findings suggest that ATP usage in the ER may increase mitochondrial OxPhos while decreasing glycolysis, i.e. an 'anti-Warburg' effect.


Subject(s)
Adenosine Triphosphate/metabolism , Calcium/metabolism , Endoplasmic Reticulum/metabolism , Mitochondria/metabolism , Animals , Biological Transport , Cations, Divalent/metabolism , Cell Line , Cricetulus , Humans , Rats
4.
J Clin Virol ; 42(1): 27-33, 2008 May.
Article in English | MEDLINE | ID: mdl-18249032

ABSTRACT

BACKGROUND: An outbreak of flavivirus encephalitis occurred in 2005 in Córdoba province, Argentina. OBJECTIVES: To characterize the epidemiologic and clinical features of that outbreak and provide the serologic results that identified St. Louis encephalitis virus (SLEV) as the etiologic agent. STUDY DESIGN: From January to May 2005, patients with symptoms of encephalitis, meningitis, or fever with severe headache were evaluated and an etiologic diagnosis achieved by detection of flavivirus-specific antibody sera and cerebrospinal fluid. RESULTS: The epidemic curve of 47 cases showed an explosive outbreak starting in January 2005 with one peak in mid-February and a second peak in mid-March; the epidemic ended in May. Cases occurred predominantly among persons 60 years and older. Nine deaths were reported. SLEV antibodies, when detected in 47 patients studied, had a pattern characteristic of a primary SLEV infection. CONCLUSIONS: Even though isolated cases of St. Louis encephalitis have been reported in Argentina, this is the first description of a large SLEV encephalitis outbreak in Argentina.


Subject(s)
Disease Outbreaks , Encephalitis, St. Louis/epidemiology , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Antibodies, Viral/blood , Antibodies, Viral/cerebrospinal fluid , Argentina/epidemiology , Child , Encephalitis Virus, St. Louis/isolation & purification , Encephalitis, St. Louis/diagnosis , Encephalitis, St. Louis/mortality , Female , Humans , Male , Middle Aged , Seasons , Serologic Tests
5.
Am J Trop Med Hyg ; 76(4): 768-73, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17426185

ABSTRACT

Efficacy of the new antipoxvirus compound ST-246 was evaluated as treatment of monkeypox (MPX) virus infection in a ground squirrel model of the disease. Ground squirrels were given a lethal dose of MPX virus and were then treated orally at various times post-inoculation (pi) with 100 mg/kg/day of ST-246. Morbidity and mortality, clinical laboratory results, viral load, and pathology of placebo and treatment groups were compared. All animals that started treatment with ST-246 on days 0, 1, 2, and 3 pi survived lethal challenge with MPX virus; 67% of animals treated on day 4 pi also survived. In contrast, 100% of the placebo group died. Most of the ST-246-treated animals showed no evidence of clinical disease or alteration of baseline clinical laboratory values and had minimal histopathologic changes. These results suggest that ST-246 is a promising candidate for early treatment of severe orthopoxvirus infection.


Subject(s)
Animal Diseases/drug therapy , Animal Diseases/virology , Antiviral Agents/therapeutic use , Benzamides/therapeutic use , Indoles/therapeutic use , Mpox (monkeypox)/veterinary , Sciuridae/virology , Animals , Antiviral Agents/pharmacokinetics , Benzamides/pharmacokinetics , Drug Administration Schedule , Indoles/pharmacokinetics , Isoindoles , Liver/pathology , Lung/pathology , Models, Animal , Mpox (monkeypox)/drug therapy , Mpox (monkeypox)/mortality , Mpox (monkeypox)/virology , Spleen/pathology , Time Factors
6.
Am J Trop Med Hyg ; 76(2): 299-306, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17297039

ABSTRACT

To further study the phenomenon of flavivirus persistent infection, golden hamsters (Mesocricetus auratus) were inoculated intraperitoneally with a low pathogenicity strain of St. Louis encephalitis virus (SLEV). After inoculation, the animals remained asymptomatic and developed high levels of specific neutralizing antibodies in their sera. However, about one half of the hamsters continued to shed infectious SLEV in their urine for prolonged periods of time. By co-cultivation, SLEV was recovered from selected tissues (kidney, lung, and brain) of some of the animals for up to 185 days after initial infection. Although no specific histopathologic changes were observed in these tissues, SLEV antigen was shown by immunohistochemistry in the interstitium and tubular epithelium of the renal cortex and in a few large neurons of the cerebral cortex. Seventeen SLEV isolates from urine and tissues of the chronically infected hamsters were sequenced. In comparison with the infecting parent SLEV strain, two common mutations and amino acid substitutions were observed in all of the hamster isolates. The findings of this study were very similar to previous descriptions of chronic West Nile, Modoc, and tick-borne encephalitis virus infections in mammals, and they re-emphasize the potential importance of persistent flavivirus infection in vertebrates.


Subject(s)
Encephalitis Virus, St. Louis/growth & development , Encephalitis, St. Louis/virology , Animals , Antibodies, Viral/blood , Carrier State/immunology , Carrier State/virology , Cerebral Cortex/virology , Cricetinae , Disease Models, Animal , Encephalitis Virus, St. Louis/genetics , Encephalitis Virus, St. Louis/immunology , Encephalitis, St. Louis/immunology , Encephalitis, St. Louis/urine , Female , Hemagglutination Inhibition Tests , Immunohistochemistry , Kidney Cortex/virology , Mesocricetus , Point Mutation , RNA, Viral/chemistry , RNA, Viral/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA
7.
J Am Mosq Control Assoc ; 23(3): 264-75, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17939505

ABSTRACT

Associations between Culex quinquefasciatus, Aedes albopictus and West Nile virus (WNV) activity, temperature, and rainfall in Harris County, Texas 2003-06 are discussed. Human cases were highly correlated to Cx. quinquefasciatus (r = 0.87) and Ae. albopictus (r = 0.78) pools, blue jays (r = 0.83), and Ae. albopictus collected (r = 0.71), but not Cx. quinquefasciatus collected (r = 0.45). Human cases were associated with temperature (r = 0.71), not rainfall (r = 0.29), whereas temperature correlated with Ae. albopictus and Cx. quinquefasciatus collections (r = 0.88 and 0.70, respectively) and Cx. quinqueftsciatus pools (r = 0.75), but not Ae. albopictus pools (r = 0.55). Both species (collections and pools) and blue jays were weakly correlated (r 5 0.41) with rainfall, but blue jays were better correlated with Cx. quinquefasciatus pools (r = 0.87), compared with Ae. albopictus pools (r = 0.67), Ae. albopictus collections (r = 0.69), and Cx. quinquefasciatus collections (r = 0.46). Peak minimum infection rate for Cx. quinquefasciatus (4.55), and Ae. albopictus (4.41) was in August with highest human cases (17.87), blue jays (55.58), and temperature (29.01 degrees C). Between both species, blood meal analysis indicated 68.18% of Cx. quinquefasciatus mammalian hosts were dog, while 22.72% were human, whereas Ae. albopictus had higher human (44.44%) but fewer dog hosts (22.22%). Ten bird species were identified as hosts for Cx. quinquefasciatus, with northern cardinal and blue jay representing 26.66% and 20.00%, respectively. No bird feeding activity was observed in Ae. albopictus. The earliest and latest human blood meal occurred in May (Ae. albopictus) and November (Cx. quinquefasciatus); 66.66% of human host identifications between both species occurred in October-November, after the seasonal human case peak. Based upon our data, WNV activity in both mosquito species warrants further investigation of their individual roles in WNV ecology within this region.


Subject(s)
Aedes/virology , Culex/virology , Songbirds/virology , West Nile Fever/transmission , West Nile virus/isolation & purification , Animals , Dogs , Female , Humans , Rain , Rats , Seasons , Temperature , Texas/epidemiology , West Nile Fever/epidemiology
8.
Am J Trop Med Hyg ; 72(3): 320-4, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15772329

ABSTRACT

Adult hamsters that survived experimental West Nile virus (WNV) infection developed persistent viruria. Infectious WNV could be cultured from their urine for up to 52 days. Immunohistochemical examination of kidneys of viruric animals showed foci of WNV antigen in renal tubular epithelial and vascular endothelial cells. These findings are compatible with virus replication and persistent infection of renal epithelial cells. The potential clinical and virologic significance of these findings as well as their possible epidemiologic importance are discussed.


Subject(s)
Virus Shedding , West Nile Fever/transmission , Animals , Antigens, Viral/analysis , Cricetinae , Disease Models, Animal , Kidney/pathology , Kidney/virology , Liver/virology , Mesocricetus , West Nile virus/isolation & purification
9.
Am J Trop Med Hyg ; 73(4): 803-7, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16222029

ABSTRACT

Recent studies have shown that West Nile virus (WNV) can induce an asymptomatic persistent infection in the kidneys of experimentally infected hamsters. The chronically infected rodents shed virus in their urine for up to 8 months, despite the disappearance of viremia and the development of high levels of neutralizing antibodies. WNV, like most members of the Japanese encephalitis virus complex (Flavivirus; Flaviviridae), is assumed to be mainly neurotropic; little is known about the genetic basis for its renal tropism. In this study, complete sequence analyses were done to compare four WNV isolates from the urines of persistently infected hamsters with the wild-type parent virus (NY 385-99). Nucleotide changes, ranging from 0.05% to 0.09%, were identified in all of the WNV isolates from urine; most of the changes were in coding regions, causing amino acid substitutions in the E, NS1, NS2B, and NS5 proteins. The genetic changes associated with renal tropism were also accompanied by a loss of virulence for hamsters and a change in plaque morphology.


Subject(s)
Amino Acid Substitution , Kidney/virology , West Nile Fever/pathology , West Nile virus/genetics , West Nile virus/pathogenicity , Amino Acid Sequence , Animals , Base Sequence , Chronic Disease , Cricetinae , Disease Models, Animal , Female , Kidney/pathology , Molecular Sequence Data , Sequence Analysis, DNA , Urine/virology , Virulence , West Nile Fever/virology , West Nile virus/classification
10.
Vaccine ; 33(19): 2203-2206, 2015 May 05.
Article in English | MEDLINE | ID: mdl-25812841

ABSTRACT

A rabies vaccine that is thermostable over a range of ambient environmental temperatures would be highly advantageous, especially for tropical regions with challenging cold-chain storage where canine rabies remains enzootic resulting in preventable human mortality. Live attenuated rabies virus (RABV) strain ERAG333 (R333E) was preserved by vaporization (PBV) in a dry, stable foam. RABV stabilized using this process remains viable for at least 23 months at 22°C, 15 months at 37°C, and 3h at 80°C. An antigen capture assay revealed RABV PBV inactivated by irradiation contained similar levels of antigen as a commercial vaccine. Viability and antigen capture testing confirmed that the PBV process stabilized RABV with no significant loss in titer or antigen content. Live attenuated and inactivated RABV PBV both effectively induced RABV neutralizing antibodies and protected mice from peripheral RABV challenge. These results demonstrate that PBV is an efficient method for RABV stabilization.


Subject(s)
Rabies Vaccines/immunology , Volatilization , Animals , Drug Stability , Female , Humans , Mice , Microbial Viability , Rabies virus/physiology , Temperature , Time Factors , Vaccines, Attenuated/immunology , Viral Load
11.
Am J Trop Med Hyg ; 70(6): 676-81, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15211013

ABSTRACT

Harris County, Texas, is an endemic area of St. Louis encephalitis (SLE); and an active surveillance program that monitors SLE virus activity in mosquitoes, birds, and humans has been in place there for the past 28 years. In June of 2002, West Nile (WN) virus appeared in Houston and quickly spread throughout the region. This report describes the results of 12 years of SLE surveillance in Harris County and the contrasting pattern of WN virus activity, when it arrived in 2002. Our data indicate that both SLE and WN viruses can coexist, despite their ecologic, antigenic, and genetic similarities, and that both viruses will probably persist in this geographic region.


Subject(s)
Bird Diseases/epidemiology , Dog Diseases/epidemiology , Encephalitis Virus, St. Louis , Encephalitis, St. Louis/epidemiology , West Nile Fever/epidemiology , West Nile virus , Animals , Animals, Wild/virology , Antibodies, Viral/blood , Bird Diseases/virology , Birds/virology , Culex/virology , Dog Diseases/virology , Dogs , Encephalitis Virus, St. Louis/immunology , Encephalitis Virus, St. Louis/isolation & purification , Encephalitis, St. Louis/virology , Endemic Diseases , Humans , Prevalence , Texas/epidemiology , West Nile Fever/virology , West Nile virus/immunology , West Nile virus/isolation & purification
12.
Vector Borne Zoonotic Dis ; 4(3): 204-9, 2004.
Article in English | MEDLINE | ID: mdl-15631064

ABSTRACT

The sensitivity of the VecTest antigen-capture and RT-PCR assays were compared to brain tissue culture in Vero cells for the detection of WNV in a sample of dead birds collected in East Texas and southern Louisiana during the summer of 2003. Cell culture was used as the gold standard, because it yielded the most positives. Direct culture of brain tissue and the WNV antigen-capture assay, done on oropharyngeal swabs, gave statistically comparable results (46% and 40% positive, respectively). In contrast, RT-PCR done on brain homogenates was significantly less sensitive than direct tissue culture (33% compared to 46%, respectively). Results indicated that RT-PCR may not be consistently the most sensitive assay for detection of WNV in dead bird brain tissue and that the VecTest antigen-capture assay has a number of advantages over the other two detection techniques for routine surveillance activities.


Subject(s)
Bird Diseases/diagnosis , Immunoassay/veterinary , Reverse Transcriptase Polymerase Chain Reaction/veterinary , West Nile Fever/veterinary , West Nile virus/isolation & purification , Animals , Antigens, Viral/analysis , Bird Diseases/virology , Brain/virology , Chlorocebus aethiops , Immunoassay/methods , Population Surveillance , Reverse Transcriptase Polymerase Chain Reaction/methods , Sensitivity and Specificity , Vero Cells , West Nile Fever/diagnosis , West Nile virus/genetics , West Nile virus/immunology
13.
Am J Trop Med Hyg ; 79(6): 955-62, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19052311

ABSTRACT

The efficacy of a recombinant subunit West Nile (WN) vaccine candidate was determined in a hamster model of encephalitis. Animals included young, aged, and immunocompromised animals in an effort to simulate key groups at risk of WN virus-induced disease. Groups of aged (12 month old), weanling, and adult hamsters rendered leukopenic after immunization were immunized subcutaneously with a WN virus recombinant envelope protein (WN-80E) with or without WN virus non-structural protein 1 (NS1) mixed with adjuvant or adjuvant alone. A challenge dose of wild-type WN virus was administered to produce 40-100% mortality in the control hamsters. The recombinant antigen preparations containing WN-80E with or without WN NS1 gave similar results. Hamsters in both groups had a strong antibody response after immunization, and none of the aged or weanling animals became ill or developed detectable viremia after challenge with WN virus at 2 weeks after booster vaccination. However, mortality among the control animals (administered adjuvant without antigen) at 2 weeks after booster challenge was 40-60%. In hamsters rendered leukopenic after immunization, survival rates up to 80% were observed, and a low-level viremia was detected in the vaccinated and challenged hamsters. The survival rate was significantly (P<0.05) higher in animals vaccinated with a higher dose of WN-80E than a lower dose. The addition of NS1 did not significantly affect survival after challenge. In contrast, all of the control animals that received adjuvant only developed a very high level of viremia, and the mortality rate was 100%. These findings indicate that the recombinant WN vaccines induced antibody in and afforded protection to young and aged hamsters and immunosuppressed hamsters.


Subject(s)
Protein Subunits/immunology , Recombinant Proteins/immunology , Viral Vaccines/immunology , West Nile Fever/prevention & control , Aging , Animals , Cricetinae , Cyclophosphamide/pharmacology , Dose-Response Relationship, Immunologic , Female , Immunocompromised Host , Immunosuppressive Agents/pharmacology , Mesocricetus , Time Factors , Viremia , Weaning , West Nile Fever/pathology
14.
Vaccine ; 25(15): 2913-8, 2007 Apr 12.
Article in English | MEDLINE | ID: mdl-17067727

ABSTRACT

The efficacy of a new recombinant subunit West Nile virus (WNV) vaccine candidate was determined in a hamster model of meningoencephalitis. Groups of hamsters were immunized subcutaneously with a WNV recombinant envelope protein (80E) with or without WNV non-structural protein 1 (NS1) mixed with adjuvant or adjuvant alone. At 2 weeks, 6 months, and 12 months after two immunizations at 4 week intervals with the respective immunogens, groups of animals were challenged via the intraperitoneal route with a virulent strain of WNV. The two recombinant antigen preparations gave similar results; hamsters in both groups had a strong antibody response following immunization, and none of the animals became ill or developed detectable viremia after challenge with WNV at 2 weeks or 6 months post-booster vaccination. In contrast, mortality among the control animals at 2 weeks post-booster challenge was 73%, and at 6 months post-booster, the mortality was 53% among the control animals. When challenged 12 months after the booster vaccination, a low level viremia was detected in some of the vaccinated hamsters, and one hamster became sick, but recovered. In contrast, all of the control animals that received adjuvant only developed a viremia, and the mortality rate was 77%. These results with the recombinant subunit WNV vaccine are very encouraging and warrant further animal studies to evaluate its potential use to protect humans against WNV disease.


Subject(s)
Viral Vaccines/pharmacology , West Nile Fever/prevention & control , West Nile virus/immunology , Animals , Cricetinae , Female , Vaccines, Subunit/genetics , Vaccines, Subunit/immunology , Vaccines, Subunit/pharmacology , Vaccines, Synthetic/genetics , Vaccines, Synthetic/immunology , Vaccines, Synthetic/pharmacology , Viral Vaccines/genetics , Viral Vaccines/immunology , West Nile Fever/immunology , West Nile Fever/virology , West Nile virus/genetics
15.
Vaccine ; 25(3): 414-23, 2007 Jan 05.
Article in English | MEDLINE | ID: mdl-16996661

ABSTRACT

While several West Nile vaccines are being developed, none are yet available for humans. In this study aimed at developing a vaccine for humans, West Nile virus (WNV) envelope protein (E) and non-structural protein 1 (NS1) were produced in the Drosophila S2 cell expression system. The C-terminal 20% of the E protein, which contains the membrane anchor portion, was deleted, thus allowing for efficient secretion of the truncated protein (80E) into the cell culture medium. The proteins were purified by immunoaffinity chromatography (IAC) using monoclonal antibodies that were flavivirus envelope protein group specific (for the 80E) or flavivirus NS1 group specific (for NS1). The purified proteins were produced in high yield and used in conjunction with adjuvant formulations to vaccinate mice. The mice were tested for both humoral and cellular immune responses by a plaque reduction neutralization test and ELISA, and by lymphocyte proliferation and cytokine production assays, respectively. The results revealed that the 80E and the NS1 proteins induced both high-titered ELISA and neutralizing antibodies in mice. Splenocytes from immunized mice, cultured in vitro with the vaccine antigens as stimulants, showed excellent proliferation and production of cytokines (IFN-gamma, IL-4, IL-5, and IL-10). The level of antigen-stimulated lymphocyte proliferation and cytokine production was comparable to the level obtained from mitogen (phytohemagglutinin or pokeweed) stimulation, indicating a robust cellular response as well. These findings are encouraging and warrant further in vivo studies to determine the protective efficacy of the WNV vaccine candidate.


Subject(s)
Viral Vaccines/immunology , West Nile Fever/immunology , West Nile Fever/prevention & control , West Nile virus/immunology , Adjuvants, Immunologic , Animals , Antibodies, Viral/analysis , Antibodies, Viral/biosynthesis , Antibody Formation/immunology , Cell Proliferation/drug effects , Cytokines/biosynthesis , Enzyme-Linked Immunosorbent Assay , Female , Immunity, Cellular , Lymphocytes/drug effects , Lymphocytes/immunology , Mice , Mice, Inbred BALB C , Spleen/cytology , Spleen/immunology , Vaccines, Synthetic/immunology , West Nile Fever/virology
16.
Emerg Infect Dis ; 11(4): 539-45, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15829191

ABSTRACT

Studies of experimental infection of prairie dogs (Cynomys ludovicianus) with monkeypox virus are described. After intraperitoneal infection, all of the animals died within 11 days. Virus was cultured from their blood and oropharynx several days before death; at necropsy, most of the organs tested contained monkeypox virus. Marked hepatic and splenic necrosis were observed, along with mild inflammatory changes in the lungs. After intranasal (IN) infection, the primary pathologic changes were in the lungs and pleural cavity. Some of the IN infected animals (40%) survived, and monkeypox virus could be cultured from their nasal discharge and oropharynx for <22 days. Ulcerative lesions also developed on the lips, tongue, and buccal mucosa of the surviving animals. Our findings support an earlier report, which suggested that infected prairie dogs can transmit monkeypox virus by respiratory and mucocutaneous contact with susceptible animals and persons.


Subject(s)
Monkeypox virus/physiology , Mpox (monkeypox)/veterinary , Sciuridae/virology , Animals , Antibodies, Viral/blood , Brain/virology , Heart/virology , Liver/virology , Lung/virology , Monkeypox virus/immunology , Spleen/virology
17.
J Infect Dis ; 192(2): 287-95, 2005 Jul 15.
Article in English | MEDLINE | ID: mdl-15962223

ABSTRACT

Golden hamsters (Mesocricetus auratus) experimentally infected with West Nile virus (WNV) developed chronic renal infection and persistent shedding of virus in urine for up to 8 months, despite initial rapid clearance of virus from blood and the timely appearance of high levels of specific neutralizing antibodies. Infectious WNV could be recovered by direct culture of their urine and by cocultivation of kidney tissue for up to 247 days after initial infection. Only moderate histopathologic changes were observed in the kidneys or brain of the chronically infected hamsters, although WNV antigen was readily detected by immunohistochemistry within epithelium, interstitial cells, and macrophages in the distal renal tubules. Comparison of WNV isolates from serial urine samples from individual hamsters over several months indicated that the virus underwent both genetic and phenotypic changes during persistent infection. These findings are similar to previous reports of persistent infection with tickborne encephalitis and Modoc viruses.


Subject(s)
Flavivirus Infections/physiopathology , West Nile Fever/physiopathology , Animals , Antibodies, Viral/blood , Antibody Formation , Antigens, Viral/analysis , Cricetinae , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Kidney/pathology , Kidney/virology , Male , Mesocricetus , Viremia/immunology , West Nile Fever/pathology , West Nile virus/immunology
18.
Virology ; 342(2): 252-65, 2005 Nov 25.
Article in English | MEDLINE | ID: mdl-16137736

ABSTRACT

The distribution of West Nile virus has expanded in the past 6 years to include the 48 contiguous United States and seven Canadian provinces, as well as Mexico, the Caribbean islands, and Colombia. The suggestion of the emergence of a dominant genetic variant has led to an intensive analysis of isolates made across North America. We have sequenced the pre-membrane and envelope genes of 74 isolates and the complete genomes of 25 isolates in order to determine if a dominant genotype has arisen and to better understand how the virus has evolved as its distribution has expanded. Phylogenetic analyses revealed the continued presence of genetic variants that group in a temporally and geographically dependent manner and provide evidence that a dominant variant has emerged across much of North America. The implications of these findings are discussed as they relate to transmission and spread of the virus in the Western Hemisphere.


Subject(s)
Genes, Viral , Genome, Viral , West Nile virus/genetics , Genetic Variation , Molecular Sequence Data , North America , Species Specificity , Viral Envelope Proteins/genetics
19.
Emerg Infect Dis ; 10(9): 1563-7, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15498157

ABSTRACT

A proposed new small-animal (rodent) model for studying the pathogenesis and treatment of severe orthopoxvirus infections is described. Thirteen-lined ground squirrels (Spermophilus tridecemlineatus) were infected intraperitoneally and intranasally with monkeypox virus (MPXV). A fulminant illness developed in all animals, and they died 6-9 days after infection. Virus was cultured from the blood and oropharynx several days before death; at necropsy, all of the organs tested contained relatively high titers of MPXV. The major pathologic findings were in the liver, which showed centrilobular necrosis, steatosis, and basophilic inclusion bodies in hepatocytes. Splenic necrosis was also observed, as well as interstitial inflammation in the lungs. The pathologic features of MPXV in ground squirrels are similar to that described with MPXV in macaques and severe variola (smallpox) virus infection in humans.


Subject(s)
Monkeypox virus , Sciuridae , Animals , Disease Models, Animal , Disease Susceptibility/veterinary , Hepatocytes/pathology , Hepatocytes/ultrastructure , Hepatocytes/virology , Liver/pathology , Liver/virology , Mpox (monkeypox)/immunology , Mpox (monkeypox)/pathology , Mpox (monkeypox)/veterinary , Rodent Diseases/virology , Sciuridae/virology , Spleen/pathology , Spleen/virology
20.
Virology ; 330(1): 342-50, 2004 Dec 05.
Article in English | MEDLINE | ID: mdl-15527859

ABSTRACT

In order to understand how West Nile virus (WNV) has evolved since its introduction into North America, we have studied the genetic and phenotypic variation among WNV isolates collected in various areas during consecutive transmission seasons. The present report describes for the first time phenotypic changes occurring in the North American WNV population. Several isolates collected in Texas during 2003 display a small plaque (sp) and temperature sensitive (ts) phenotype, as well as reduced replication in cell culture, in comparison to isolates collected in 2002 and New York in 1999. Studies of mouse neuroinvasiveness/neurovirulence also indicate that several of these isolates were attenuated in neuroinvasiveness, but not for neurovirulence. The complete genome and deduced amino acid sequences of several of these isolates have been determined in order to map the mutations responsible for this phenotypic variation. These data indicate microevolution of WNV and the emergence of isolates exhibiting phenotypic variation.


Subject(s)
Genetic Variation , West Nile virus/physiology , Animals , Birds/virology , Brain/virology , Chlorocebus aethiops , Texas , Vero Cells , Viral Plaque Assay , West Nile virus/genetics , West Nile virus/isolation & purification , West Nile virus/pathogenicity
SELECTION OF CITATIONS
SEARCH DETAIL